Search by Drug Name or NDC

NDC 72789-0090-30 SILODOSIN 8 mg/1 Details

SILODOSIN 8 mg/1

SILODOSIN is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is SILODOSIN.

MedlinePlus Drug Summary

Silodosin is used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia; BPH), which include difficulty urinating (hesitation, dribbling, weak stream, and incomplete bladder emptying), painful urination, and urinary frequency and urgency. Silodosin is in a class of medications called alpha-blockers. It relieves the symptoms of BPH by relaxing the muscles of the bladder and prostate.

Related Packages: 72789-0090-30
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Silodosin

Product Information

NDC	72789-0090
Product ID	72789-090_06318bbd-9c06-921f-e063-6294a90a9077
Associated GPIs	56852060000140
GCN Sequence Number	064847
GCN Sequence Number Description	silodosin CAPSULE 8 MG ORAL
HIC3	Q9B
HIC3 Description	BENIGN PROSTATIC HYPERTROPHY/MICTURITION AGENTS
GCN	16858
HICL Sequence Number	036119
HICL Sequence Number Description	SILODOSIN
Brand/Generic	Generic
Proprietary Name	SILODOSIN
Proprietary Name Suffix	n/a
Non-Proprietary Name	SILODOSIN
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	8
Active Ingredient Units	mg/1
Substance Name	SILODOSIN
Labeler Name	PD-Rx Pharmaceuticals, Inc.
Pharmaceutical Class	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA210687
Listing Certified Through	2024-12-31

Package

NDC 72789-0090-30 (72789009030)

Pricing Information	N/A
NDC Package Code	72789-090-30
Billing NDC	72789009030
Package	30 CAPSULE in 1 BOTTLE, PLASTIC (72789-090-30)
Marketing Start Date	2020-06-23
NDC Exclude Flag	N